Table 1 Clinical characteristics of the patient cohort
N = 102 | |
|---|---|
Sex, N (%) | |
Male | 69 (67.6) |
Female | 33 (32.4) |
Age (years), median (range) | 60 (27–74) |
BMI (kg/m2), median (range) | 23.2 (14.8–33.4) |
AV distance (cm), median (range) | 4.0 (0.0–8.0) |
CEA level (ng/mL), median (range) | 3.6 (0.1–381.0) |
cT stage N (%) | |
T2/T3/T4 | 2 (2.0)/ 77 (75.5)/ 23 (22.5) |
cN stage, N (%) | |
Negative | 52 (51.0) |
Positive | 50 (49.0) |
Clinical LPLN metastasis, N (%) | |
Negative | 78 (76.5) |
Positive | 24 (23.5) |
Clinical CRM, N (%) | |
Negative | 73 (71.6) |
Positive | 29 (28.4) |
mrEMVI, N (%) | |
Negative | 78 (76.5) |
Positive | 24 (23.5) |
ymrEMVI, N (%) | |
Negative | 80 (78.4) |
Positive | 22 (21.6) |
Surgical procedure, N (%) | |
Low anterior resection | 16 (15.6) |
Intersphincteric resection | 73 (71.6) |
Abdominoperineal resection | 12 (11.8) |
Total colectomy | 1 (1.0) |
Operation type, N (%) | |
Open | 33 (32.4) |
Laparoscopic | 69 (67.6) |